chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Pruritus, Vulvovaginal pruritus
Clinical narrative: itching on scalp; Vaginal itching; Itching on arm; Itching around injection site; This spontaneous case was reported by a consumer and describes the occurrence of VULVOVAGINAL PRURITUS (Vaginal itching), PRURITUS (Itching on arm and scalp) and INJECTION SITE PRURITUS (Itching around injection site) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced VULVOVAGINAL PRURITUS (Vaginal itching), PRURITUS (Itching on arm and scalp) and INJECTION SITE PRURITUS (Itching around injection site). At the time of the report, VULVOVAGINAL PRURITUS (Vaginal itching), PRURITUS (Itching on arm and scalp) and INJECTION SITE PRURITUS (Itching around injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications are not taking Treatment information includes non-itch cream OTC
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: Large blotchy area of redness; Swelling; General tenderness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Large blotchy area of redness), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE PAIN (General tenderness) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by reporter.  No concomitant medication reported.     On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Large blotchy area of redness), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE PAIN (General tenderness). On 17-Jan-2021, VACCINATION SITE ERYTHEMA (Large blotchy area of redness), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE PAIN (General tenderness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received a dose that past 24 hs withdrawn from the vial; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received a dose that past 24 hs withdrawn from the vial) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received a dose that past 24 hs withdrawn from the vial). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received a dose that past 24 hs withdrawn from the vial) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: poison ivy on 25feb2021 and a rash developed. Patient reports the rash started on their right wrist and moved to the entire right arm, then traveled to his left arm, as well as a small patch on their should/neck area and around his belt line.; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH (poison ivy on 25feb2021 and a rash developed. Patient reports the rash started on their right wrist and moved to the entire right arm, then traveled to his left arm, as well as a small patch on their should/neck area and around his belt line.) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Cough. Concomitant products included IBUPROFEN (ADVIL [IBUPROFEN]) for an unknown indication.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced RASH (poison ivy on 25feb2021 and a rash developed. Patient reports the rash started on their right wrist and moved to the entire right arm, then traveled to his left arm, as well as a small patch on their should/neck area and around his belt line.). The patient was treated with METHYLPREDNISOLONE (MEDROL [METHYLPREDNISOLONE]) for Symptomatic treatment, at an unspecified dose and frequency and CLOBETASOL (topical) for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, RASH (poison ivy on 25feb2021 and a rash developed. Patient reports the rash started on their right wrist and moved to the entire right arm, then traveled to his left arm, as well as a small patch on their should/neck area and around his belt line.) had not resolved.            Concomitant medications also included Cough drops as needed.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Follow-up information received on 07-JUL-2021 contains no new information.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Vaccination site erythema, Vaccination site pruritus, Vaccination site rash, Vaccination site urticaria
Clinical narrative: Hypersensitivity reaction; Local tching/pruritus; hives at injection site/broke out in a rash and hives at the injection site.; Local Redness/erythema; rash at injection site/broke out in a rash and hives at the injection site.; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Hypersensitivity reaction), VACCINATION SITE PRURITUS (Local tching/pruritus), VACCINATION SITE URTICARIA (hives at injection site/broke out in a rash and hives at the injection site.), VACCINATION SITE ERYTHEMA (Local Redness/erythema) and VACCINATION SITE RASH (rash at injection site/broke out in a rash and hives at the injection site.) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to antibiotic (Cefazolin - Asthma) since 2014, Sulfonamide allergy (Sulfa antibiotics - Rash), Allergy to intravenous contrast media (Iodine IV contrast - Asthma), Allergy to antibiotic (Gentamicin - Irritation), Allergy to vaccine, Osteoarthritis since 1984, Migraine headache since 1966 and Scoliosis. Concomitant products included AMLODIPINE from 2019 to an unknown date for Blood pressure management, TAMOXIFEN from 2014 to an unknown date for Chemoprophylaxis NOS, CICLOSPORIN (RESTASIS) for Dry eye, RANITIDINE from an unknown date to May 2021 for Esophageal reflux, MINOXIDIL for Hair loss, CIMETIDINE and TEMAZEPAM for an unknown indication.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (Hypersensitivity reaction), VACCINATION SITE PRURITUS (Local tching/pruritus) and VACCINATION SITE ERYTHEMA (Local Redness/erythema). an unknown date, the patient experienced VACCINATION SITE URTICARIA (hives at injection site/broke out in a rash and hives at the injection site.) and VACCINATION SITE RASH (rash at injection site/broke out in a rash and hives at the injection site.). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form. At the time of the report, HYPERSENSITIVITY (Hypersensitivity reaction), VACCINATION SITE PRURITUS (Local tching/pruritus), VACCINATION SITE URTICARIA (hives at injection site/broke out in a rash and hives at the injection site.), VACCINATION SITE ERYTHEMA (Local Redness/erythema) and VACCINATION SITE RASH (rash at injection site/broke out in a rash and hives at the injection site.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: No specific follow-up information recorded. On 28-Jun-2021: Follow-up information received on 28 Jun 2021 included no new information.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site bruising, Pain in extremity
Clinical narrative: Arm started hurting; bruise at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE BRUISING (bruise at the injection site) and PAIN IN EXTREMITY (Arm started hurting) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Asthma and Blood pressure high. Concomitant products included METFORMIN for an unknown indication.   On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced INJECTION SITE BRUISING (bruise at the injection site). On 02-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm started hurting). At the time of the report, INJECTION SITE BRUISING (bruise at the injection site) and PAIN IN EXTREMITY (Arm started hurting) had not resolved.            Blood pressure and asthma medications are the other concomitant medications reported by investigator. Ointment is the treatment medication reported by reporter.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Age not checked at time of vaccination; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Age not checked at time of vaccination) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021 at 9:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Age not checked at time of vaccination). On 12-Feb-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Age not checked at time of vaccination) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment medication was reported   Most recent FOLLOW-UP information incorporated above includes: On 17-Jun-2021: patient demographics, vaccine  information such as batch number anatomical location was updated.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis, Oropharyngeal pain, Rash, Vaccination site pruritus
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (head cold sore throat), OROPHARYNGEAL PAIN (head cold sore throat), RASH (rash on entire right arm) and VACCINATION SITE PRURITUS (site is itchy) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced NASOPHARYNGITIS (head cold sore throat), OROPHARYNGEAL PAIN (head cold sore throat), RASH (rash on entire right arm) and VACCINATION SITE PRURITUS (site is itchy). At the time of the report, NASOPHARYNGITIS (head cold sore throat), OROPHARYNGEAL PAIN (head cold sore throat), RASH (rash on entire right arm) and VACCINATION SITE PRURITUS (site is itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. No treatment information was provided.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (pregnant) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 032L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 22-Mar-2021. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (pregnant). At the time of the report, EXPOSURE DURING PREGNANCY (pregnant) had resolved.            No concomitant medications reported.  Treatment information not reported.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain
Clinical narrative: ear pain above my ear on my head; This spontaneous case was reported by an other health care professional and describes the occurrence of EAR PAIN (ear pain above my ear on my head) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Jan-2021, the patient experienced EAR PAIN (ear pain above my ear on my head). At the time of the report, EAR PAIN (ear pain above my ear on my head) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications provided.  No treatment medications provided.
Sex: M
Vaccine: COVID19
Symptoms: Hyperhidrosis, Nausea, Pyrexia
Clinical narrative: Sweats day after 2nd dose; Low grade fever; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweats day after 2nd dose), PYREXIA (Low grade fever) and NAUSEA (Nausea) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033c21a) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (Sweats day after 2nd dose), PYREXIA (Low grade fever) and NAUSEA (Nausea). At the time of the report, HYPERHIDROSIS (Sweats day after 2nd dose), PYREXIA (Low grade fever) and NAUSEA (Nausea) outcome was unknown.            No concomitant medication were reported.  No treatment information was reported  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Asthenia, Nausea
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (very weak) and NAUSEA (nauseous) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by reporter. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ASTHENIA (very weak) and NAUSEA (nauseous). At the time of the report, ASTHENIA (very weak) and NAUSEA (nauseous) outcome was unknown. No concomitant medications were reported. No laboratory details were  provided. No treatment medications were reported. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Urine analysis, Vomiting
Clinical narrative: 5 hrs after I developed severe reaction and could not stop vomiting for following 48 hrs; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (5 hrs after I developed severe reaction and could not stop vomiting for following 48 hrs) and NAUSEA (Nausea) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003C21A and G41C21A) for COVID-19 vaccination.     The patient's past medical history included Shoulder pain (Worsening due to neck and back injuries from vehicle accident.) on 15-Jun-2016, Back pain (Worsening due to neck and back injuries from vehicle accident.) on 15-Jun-2016, Neck pain (Vehicle accident.) on 15-Jul-2019, Back pain (Vehicle accident.) on 15-Jul-2019 and Illness from 02-May-2021 to 04-May-2021. Concurrent medical conditions included Migraine (Worsening due to neck and back injuries from vehicle accident .) since 01-Jan-1977. Concomitant products included DEXTROMETHORPHAN HYDROBROMIDE, PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE (DAYQUIL COLD & FLU) from 01-May-2021 to an unknown date for Allergy, CLONAZEPAM from 20-Feb-2020 to an unknown date for Anxiety, QUETIAPINE from 10-Oct-2020 to an unknown date for Bipolar depression, OXYCODONE HYDROCHLORIDE, PARACETAMOL (OXYCODONE AND ACETAMINOPHEN) from 18-Jun-2020 to an unknown date and CYCLOBENZAPRINE HCL from 20-Oct-2020 to an unknown date for Chronic pain.   On 02-May-2021 at 5:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-May-2021 at 5:30 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-May-2021, the patient experienced VOMITING (5 hrs after I developed severe reaction and could not stop vomiting for following 48 hrs) and NAUSEA (Nausea). The patient was treated with DIMENHYDRINATE (DRAMAMINE) on 04-May-2021 at a dose of UNK dosage form. On 04-May-2021, VOMITING (5 hrs after I developed severe reaction and could not stop vomiting for following 48 hrs) and NAUSEA (Nausea) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-May-2021, Urine analysis: postive (Positive) Positive for fentanyl use.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient had taken pesto and OTC sleeping meds along with pain medicines to try to sleep.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Follow-up information received on 15 Jul 2021 contains significant information-Updated patient information, New events:  Nausea. And updated event outcome: Recovered.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper
Clinical narrative: she experienced severe stomach ache after receiving her first dose of Moderna Covid-19 vaccine.; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (she experienced severe stomach ache after receiving her first dose of Moderna Covid-19 vaccine.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (she experienced severe stomach ache after receiving her first dose of Moderna Covid-19 vaccine.). At the time of the report, ABDOMINAL PAIN UPPER (she experienced severe stomach ache after receiving her first dose of Moderna Covid-19 vaccine.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications provided.  No treatment drugs provided.
Sex: U
Vaccine: COVID19
Symptoms: Adverse reaction
Clinical narrative: I had a bad side effect and have been advised not to take the second; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (I had a bad side effect and have been advised not to take the second) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (I had a bad side effect and have been advised not to take the second). At the time of the report, ADVERSE REACTION (I had a bad side effect and have been advised not to take the second) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain, Pruritus, Pyrexia, Vomiting
Clinical narrative: itching; aches and pains; fever; headache; throwing up; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching), PAIN (aches and pains), PYREXIA (fever), HEADACHE (headache) and VOMITING (throwing up) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) for an unknown indication.    On 11-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jun-2021, the patient experienced PRURITUS (itching), PAIN (aches and pains), PYREXIA (fever), HEADACHE (headache) and VOMITING (throwing up). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of unknown. At the time of the report, PRURITUS (itching), PAIN (aches and pains), PYREXIA (fever), HEADACHE (headache) and VOMITING (throwing up) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Significant Followup - events outcome has been updated.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: If a person tested positive for COVID and took the first Moderna vaccine before knowing they were positive. What should they do?; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (If a person tested positive for COVID and took the first Moderna vaccine before knowing they were positive. What should they do?) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (If a person tested positive for COVID and took the first Moderna vaccine before knowing they were positive. What should they do?). At the time of the report, COVID-19 (If a person tested positive for COVID and took the first Moderna vaccine before knowing they were positive. What should they do?) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  At the time of follow-up report, it was reported that the patient was fine.  Treatment information not provided.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Updated outcome of the event.
Sex: U
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Still having headaches (second shot on 12th)) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (Still having headaches (second shot on 12th)). At the time of the report, HEADACHE (Still having headaches (second shot on 12th)) outcome was unknown.            No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: tested positive for COVID; This spontaneous case was reported by a patient and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested positive for COVID) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive for COVID). At the time of the report, SARS-COV-2 TEST POSITIVE (tested positive for COVID) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant was provided. Patient treatment information was not provided.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Dyspnoea, Vaccination site pain
Clinical narrative: shortness of breath; tension on back; sore arm at injection site immediately after the 1st shot; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), BACK PAIN (tension on back) and VACCINATION SITE PAIN (sore arm at injection site immediately after the 1st shot) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009b21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jun-2021, the patient experienced DYSPNOEA (shortness of breath), BACK PAIN (tension on back) and VACCINATION SITE PAIN (sore arm at injection site immediately after the 1st shot). At the time of the report, DYSPNOEA (shortness of breath), BACK PAIN (tension on back) and VACCINATION SITE PAIN (sore arm at injection site immediately after the 1st shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Relevant concomitant medications was reported.  Treatment information was not provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Gait disturbance, Pain in extremity
Clinical narrative: Difficult walking; right leg pain; Joint pain/ Right ankle pain/Knee pain/painful/Left shoulder extremely painful/Left knee pain/Left knee pain; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Difficult walking), PAIN IN EXTREMITY (right leg pain) and ARTHRALGIA (Joint pain/ Right ankle pain/Knee pain/painful/Left shoulder extremely painful/Left knee pain/Left knee pain) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A21A and 016M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Mar-2021, the patient experienced GAIT DISTURBANCE (Difficult walking), PAIN IN EXTREMITY (right leg pain) and ARTHRALGIA (Joint pain/ Right ankle pain/Knee pain/painful/Left shoulder extremely painful/Left knee pain/Left knee pain). At the time of the report, GAIT DISTURBANCE (Difficult walking), PAIN IN EXTREMITY (right leg pain) and ARTHRALGIA (Joint pain/ Right ankle pain/Knee pain/painful/Left shoulder extremely painful/Left knee pain/Left knee pain) had not resolved.            No relevant concomitant medications were reported  No treatment information was provided.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Ear swelling, Hypoacusis, Peripheral swelling
Clinical narrative: right ear swollen inside; can't hear good with that ear; swollen index finger in right arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen index finger in right arm), EAR SWELLING (right ear swollen inside) and HYPOACUSIS (can't hear good with that ear) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jun-2021, the patient experienced PERIPHERAL SWELLING (swollen index finger in right arm). On 16-Jun-2021, the patient experienced EAR SWELLING (right ear swollen inside) and HYPOACUSIS (can't hear good with that ear). At the time of the report, PERIPHERAL SWELLING (swollen index finger in right arm), EAR SWELLING (right ear swollen inside) and HYPOACUSIS (can't hear good with that ear) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   treatment information not provided. Concomitant medications were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Hyperhidrosis, Nausea, Pyrexia
Clinical narrative: Sweats day after 2nd dose; Weak after 2nd dose; Low grade fevers day after 2nd dose/she is run down and has a fever of 99.9 degrees F; Nausea day after 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweats day after 2nd dose), ASTHENIA (Weak after 2nd dose), PYREXIA (Low grade fevers day after 2nd dose/she is run down and has a fever of 99.9 degrees F) and NAUSEA (Nausea day after 2nd dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (Sweats day after 2nd dose), ASTHENIA (Weak after 2nd dose), PYREXIA (Low grade fevers day after 2nd dose/she is run down and has a fever of 99.9 degrees F) and NAUSEA (Nausea day after 2nd dose). At the time of the report, HYPERHIDROSIS (Sweats day after 2nd dose), ASTHENIA (Weak after 2nd dose), PYREXIA (Low grade fevers day after 2nd dose/she is run down and has a fever of 99.9 degrees F) and NAUSEA (Nausea day after 2nd dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99.9 (High) 99.9 degrees F.         Treatment information not provided. Concomitant medications were not provided.
Sex: M
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: son got sick after the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (son got sick after the vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (son got sick after the vaccine). At the time of the report, ILLNESS (son got sick after the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medication was reported. Treatment information was not provided.   This case was linked to MOD-2021-223973 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Feeling abnormal, Insomnia, Pain
Clinical narrative: feel absolutely horrible; didnt sleep at all last night; body is aching so nadly; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (feel absolutely horrible), INSOMNIA (didnt sleep at all last night) and PAIN (body is aching so nadly) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (feel absolutely horrible), INSOMNIA (didnt sleep at all last night) and PAIN (body is aching so nadly). At the time of the report, FEELING ABNORMAL (feel absolutely horrible), INSOMNIA (didnt sleep at all last night) and PAIN (body is aching so nadly) outcome was unknown.            No relevant concomitant medication was reported. Treatment information was not provided.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Headache, Pyrexia
Clinical narrative: Shortness of breath; Fever; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headache) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Jun-2021, the patient experienced PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headache). On 12-Jun-2021, the patient experienced DYSPNOEA (Shortness of breath). On 13-Jun-2021, DYSPNOEA (Shortness of breath), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headache) had resolved.            Concomitant product use was not provided by the reporter.  No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-223938 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: swollen lymph node; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swollen lymph node) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (swollen lymph node). At the time of the report, LYMPHADENOPATHY (swollen lymph node) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medication was reported. Treatment information was not provided.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Second dose not given in allowed time window; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Second dose not given in allowed time window) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Second dose not given in allowed time window). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Second dose not given in allowed time window) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medication was reported. Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Sore arm; Slight headache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and HEADACHE (Slight headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jun-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and HEADACHE (Slight headache). At the time of the report, PAIN IN EXTREMITY (Sore arm) and HEADACHE (Slight headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medication was reported. Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Asthenia, Dyspnoea, Pyrexia
Clinical narrative: Short of breath; Weak; Fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DYSPNEA (Short of breath), ASTHENIA (Weak) and PYREXIA (Fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNEA (Short of breath), ASTHENIA (Weak) and PYREXIA (Fever). At the time of the report, DYSPNEA (Short of breath), ASTHENIA (Weak) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medication was reported. Treatment information was not provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Inappropriate schedule of product administration, Myalgia
Clinical narrative: felt like she was kicked; chill that went from the back of neck to head/chills; aches in the muscle; second dose on day 25; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose on day 25), FEELING ABNORMAL (felt like she was kicked), CHILLS (chill that went from the back of neck to head/chills) and MYALGIA (aches in the muscle) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 0L6l20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LOSARTAN, METOPROLOL and AMLODIPINE for Hypertension, ASCORBIC ACID (VITCEE), TOCOPHEROL (VITAMIN E [TOCOPHEROL]), VITAMIN D NOS, POTASSIUM and MAGNESIUM for an unknown indication.   On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Jan-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose on day 25). On 26-Jan-2021, the patient experienced FEELING ABNORMAL (felt like she was kicked), CHILLS (chill that went from the back of neck to head/chills) and MYALGIA (aches in the muscle). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 25-Jan-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose on day 25) had resolved. At the time of the report, FEELING ABNORMAL (felt like she was kicked), CHILLS (chill that went from the back of neck to head/chills) and MYALGIA (aches in the muscle) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Heart rate increased
Clinical narrative: shortness of breath; sometimes a rapid heartbeat; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath) and HEART RATE INCREASED (sometimes a rapid heartbeat) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Jun-2021, the patient experienced DYSPNOEA (shortness of breath) and HEART RATE INCREASED (sometimes a rapid heartbeat). At the time of the report, DYSPNOEA (shortness of breath) and HEART RATE INCREASED (sometimes a rapid heartbeat) outcome was unknown.            No relevant concomitant medication was reported. Treatment information was not provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Skin discolouration
Clinical narrative: This spontaneous case was reported by a patient and describes the occurrence of SKIN DISCOLORATION (Black and blue discoloration of skin on back of her left knee) and ARTHRALGIA (Left knee pain) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included OLMESARTAN, BUPROPION and ACYCLOVIR [ACICLOVIR] for an unknown indication. On 01-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jun-2021, the patient experienced ARTHRALGIA (Left knee pain). On 15-Jun-2021, the patient experienced SKIN DISCOLORATION (Black and blue discoloration of skin on back of her left knee). The patient was treated with ACETYLSALICYLIC ACID (BABY ASPIRIN) for Knee pain, at an unspecified dose and frequency. At the time of the report, SKIN DISCOLOURATION (Black and blue discoloration of skin on back of her left knee) and ARTHRALGIA (Left knee pain) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Blister, Photosensitivity reaction, Pruritus
Clinical narrative: Legs and arms broke out in a rash where the sun was in contact with them/Does the vaccine cause sensitivity to the sun; Arms and legs continue to blister and peal if I out in the sun; Arms and legs exposed to sun were extremely itchy; This spontaneous case was reported by a consumer and describes the occurrence of PHOTOSENSITIVITY REACTION (Legs and arms broke out in a rash where the sun was in contact with them/Does the vaccine cause sensitivity to the sun), BLISTER (Arms and legs continue to blister and peal if I out in the sun) and PRURITUS (Arms and legs exposed to sun were extremely itchy) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 011J20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Sulfa- Stomach pain) and Allergy to antibiotic (Amoxicillin- Hives).   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-May-2021, the patient experienced PHOTOSENSITIVITY REACTION (Legs and arms broke out in a rash where the sun was in contact with them/Does the vaccine cause sensitivity to the sun), BLISTER (Arms and legs continue to blister and peal if I out in the sun) and PRURITUS (Arms and legs exposed to sun were extremely itchy). The patient was treated with HYDROCORTISONE on 06-May-2021 for Adverse event, at an unspecified dose and frequency. At the time of the report, PHOTOSENSITIVITY REACTION (Legs and arms broke out in a rash where the sun was in contact with them/Does the vaccine cause sensitivity to the sun), BLISTER (Arms and legs continue to blister and peal if I out in the sun) and PRURITUS (Arms and legs exposed to sun were extremely itchy) had not resolved.            No relevant concomitant medication was reported.  Patient experienced symptoms like redness.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Follow up received and reporter details, patient demography and medical history, dosage information, treatment and events were updated.